BioSyndexBioSyndex

For founders raising a round

Raise from a curated biopharma network — through one clean SPV.

Your first deal lists free as a founding issuer. After Precision Diligence and approval, accredited investors commit through a single ring-fenced SPV. You get one wire and one line on your cap table — not 30 individual shareholders.

  • One SPV / one cap-table entry
  • Matched on stage, modality, and network—not a blast list
  • Diligence done before you're shown to investors
Request accessI'm an accredited investor

Already approved? Sign in

How it works

  1. 1. Apply or get invited
  2. 2. We run Precision Diligence and form your SPV
  3. 3. Verified accredited investors subscribe; you close with one wire
Request access

Read the full lifecycle →

Request early access

Join the invite-only beta waitlist. We review strategic fit to protect syndicate quality.

By submitting, you agree BioSyndex, Inc. may contact you about early access and related updates. See Privacy Policy and Terms of Use.

Newsletter

Occasional notes on SPV syndication, Precision Diligence, and platform updates—no spam.

By subscribing, you agree that BioSyndex, Inc. may send you marketing emails about BioSyndex. You can unsubscribe anytime via the link in each email (CAN-SPAM compliant opt-out). See our Privacy Policy.